Company Quick10K Filing
Alamo Group
10-Q 2021-03-31 Filed 2021-05-06
10-K 2020-12-31 Filed 2021-02-26
10-Q 2020-09-30 Filed 2020-10-28
10-Q 2020-06-30 Filed 2020-07-30
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-07-31
10-Q 2019-03-31 Filed 2019-05-01
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-10-31
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-10-31
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-04
10-K 2016-12-31 Filed 2017-03-07
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-03-04
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-03-06
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-11
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-05
10-Q 2013-03-31 Filed 2013-05-03
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-07
10-K 2011-12-31 Filed 2012-03-12
10-Q 2011-09-30 Filed 2011-11-04
10-Q 2011-06-30 Filed 2011-08-05
10-Q 2011-03-31 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-03-15
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-15
8-K 2020-12-10
8-K 2020-10-28
8-K 2020-07-29
8-K 2020-05-11
8-K 2020-05-06
8-K 2020-04-07
8-K 2020-03-30
8-K 2020-03-26
8-K 2020-03-19
8-K 2020-03-10
8-K 2020-02-27
8-K 2019-12-13
8-K 2019-11-04
8-K 2019-10-30
8-K 2019-10-29
8-K 2019-09-11
8-K 2019-09-11
8-K 2019-07-31
8-K 2019-05-02
8-K 2019-05-02
8-K 2019-05-01
8-K 2019-03-06
8-K 2019-02-28
8-K 2018-10-31
8-K 2018-08-01
8-K 2018-05-03
8-K 2018-05-03
8-K 2018-04-06
8-K 2018-03-12
8-K 2018-03-01

Alamo Group Financials

ALG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash26251038343848331854644237394037354327504556177175692576444934394860
Accounts Receivable170148144170170154140170179162151183202178175193195176178196197174170196200203206235238228228270267243
Inventory122116114128123120109118121122109124182184166170175174151157160155136141153160156168175184177211206207
PP&E145143148150147148146147150155158161177173172168174173178180181180180183190197202211208214219237243244
Assets435402381451437419404427425450438465682654630647665645604646645625553635681687640746725735722852867856
Accounts Payable56474154504842565456466666694857616145555649435457595662637254706769
Long-Term Debt583295742131100000189191191209204175144173165135701281461266014711910185180166150
Liabilities1611281041641441149411610310988109312317292316317291243274269237165232258240191280251238214331324305
Stockholders' Equity273275277287292305310312322340350357370337338331348354360372376388388403423446449466474497507521543551
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue161155147156167156149158178175166171206233228208216232224211211217206215213240243238257258256262285272
Cost of Revenue123118118121131119117124134132129133161178180162165174176161159162158161159176182178191191193199212203
Gross Profit37372935393732354443363847554846515849505255485455656160666763637369
R&D
SG&A242323242524242527282827323433333434343434343634353740394039414444
Tax45436424686457445866674614825157676
Net Income910779947121167913117101511911138121217315192417152117
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating2916-18123324-20-13915-194406-1344021-5104328-1142929-28031-323343
Cash Investing-2-7-2-1-1-1-3-4-4-4-2-197-3-3-5-3-2-4-2-4-1-2-2-30-15-4-8-3-8-55-9-12
Cash Financing-27-2446-15-29-1310-11-0-10187-33-118-5-29-3328-8-30-675719-21-6786-28-1992-16-18